MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings EV/EBITDA Ratio 2011-2026 | ONVO
Annual EV/EBITDA Ratio Organovo Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.992 | -1.32 | -3 | -2.62 | -5.9 | -5 | -10.4 | -18.7 | -1.37 K | -18.6 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.992 | -1.37 K | -144 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 15.48 | -5.49 % | $ 468 M |  USA |
|
Biodesix
BDSX
|
-4.25 | $ 13.64 | -6.58 % | $ 1.77 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Thermo Fisher Scientific
TMO
|
19.3 | $ 477.84 | -2.25 % | $ 180 B | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 565.93 | -1.28 % | $ 45.5 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 118.67 | -4.61 % | $ 18.9 B | USA |
 |
Trinity Biotech plc
TRIB
|
12.6 | $ 0.61 | -0.62 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 238.69 | -2.47 % | $ 25.5 B |  Schweiz |
 |
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
21 | $ 17.21 | -0.86 % | $ 385 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 158.35 | -4.21 % | $ 7.85 B | USA |
 |
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
24.6 | $ 291.81 | -2.91 % | $ 17.4 B | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.75 | 3.38 % | $ 2.55 M | USA |
 |
Personalis
PSNL
|
-7.07 | $ 6.55 | -10.52 % | $ 388 M | USA |
 |
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
Exagen
XGN
|
-2.2 | $ 2.68 | -4.12 % | $ 57.8 M | USA |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
17.6 | $ 56.85 | -4.31 % | $ 4.27 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
-2.38 | $ 111.56 | -2.8 % | $ 5.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
-13.8 | $ 6.54 | -0.3 % | $ 273 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 266.88 | -0.56 % | $ 22.2 B | USA |
 |
VolitionRx Limited
VNRX
|
-3.45 | $ 0.2 | 0.03 % | $ 19.2 M |  Singapore |
 |
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-1.8 | $ 26.75 | -1.65 % | $ 34.7 M | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 17.11 | -2.06 % | $ 912 M | USA |
 |
Neuronetics
STIM
|
-1.45 | $ 1.4 | 5.26 % | $ 92.3 M | USA |
 |
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | Schweiz |